ZimVie Inc. (NASDAQ:ZIMV – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 550,900 shares, a decline of 18.5% from the August 31st total of 676,100 shares. Based on an average trading volume of 398,400 shares, the days-to-cover ratio is currently 1.4 days. Currently, 2.0% of the shares of the company are short sold.
Analysts Set New Price Targets
Separately, Needham & Company LLC boosted their price objective on ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Friday, August 2nd.
View Our Latest Stock Report on ZIMV
Insider Buying and Selling at ZimVie
Hedge Funds Weigh In On ZimVie
Several hedge funds have recently bought and sold shares of ZIMV. Scarborough Advisors LLC bought a new position in ZimVie in the 4th quarter valued at $28,000. Quarry LP raised its position in shares of ZimVie by 337.8% in the second quarter. Quarry LP now owns 1,655 shares of the company’s stock worth $30,000 after buying an additional 1,277 shares in the last quarter. Summit Securities Group LLC boosted its stake in ZimVie by 518.6% during the second quarter. Summit Securities Group LLC now owns 3,000 shares of the company’s stock valued at $55,000 after buying an additional 2,515 shares during the period. Heritage Wealth Advisors grew its position in ZimVie by 172,750.0% during the first quarter. Heritage Wealth Advisors now owns 6,914 shares of the company’s stock worth $114,000 after buying an additional 6,910 shares in the last quarter. Finally, The Manufacturers Life Insurance Company bought a new position in ZimVie in the 2nd quarter worth about $191,000. Hedge funds and other institutional investors own 95.63% of the company’s stock.
ZimVie Trading Up 1.0 %
NASDAQ:ZIMV opened at $15.59 on Friday. ZimVie has a 1 year low of $6.52 and a 1 year high of $22.40. The stock’s fifty day moving average price is $17.83 and its two-hundred day moving average price is $17.12. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.94 and a quick ratio of 1.43. The company has a market cap of $429.82 million, a P/E ratio of -1.12 and a beta of 2.13.
ZimVie (NASDAQ:ZIMV – Get Free Report) last issued its earnings results on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.04). ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. The company had revenue of $116.81 million during the quarter. During the same period in the prior year, the company posted $0.17 EPS. As a group, analysts expect that ZimVie will post 0.63 EPS for the current year.
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
See Also
- Five stocks we like better than ZimVie
- Insider Trades May Not Tell You What You Think
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Financial Services Stocks Investing
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Do ETFs Pay Dividends? What You Need to Know
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.